Natixis Publication of Suppl.Prospcts (4320X)

TIDM10NU

RNS Number : 4320X

Natixis

25 April 2023

The following base prospectus supplement has been approved by the UK Financial Conduct Authority and is available for viewing:

Third supplement (the "Third Supplement") to the base prospectus dated 26 July 2022 (as supplemented by the first supplement dated 15 November 2022 and the second supplement dated 1 February 2023, together the "Base Prospectus") relating to the GBP1,000,000,000 UK Debt Issuance Programme by NATIXIS and Natixis Structured Issuance S.A..

To view the full document, please paste the following URL into the address of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/4320X_1-2023-4-25.pdf

The following information has been incorporated by reference into the Base Prospectus pursuant to the Third Supplement:

Annual financial statements of Natixis Structured Issuance for the financial year ended 31 December 2022 prepared in accordance with the International Financial Reporting Standards (IFRS), available here: https://cib.natixis.com/DevInet.PIMS.ComplianceTool.Web/api/ProspectusPublicNg/DownloadDocument/264/ISSUER_FINANCIAL_SEARCH

English language version of the universal registration document and annual financial report of NATIXIS for the

year ended 31 December 2022 published on 23 March 2023 and filed with the Autorité des marches financiers under number D.23-0140, available here: https://cib.natixis.com/DevInet.PIMS.ComplianceTool.Web/api/ProspectusPublicNg/DownloadDocument/261/ISSUER_FINANCIAL_SEARCH

A copy of each document above has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

Name: Régis PARRIMOND

Email: [e-mail]

Tel: [phone]

Name: Charlotte LETELLIER

Email: [e-mail]

Tel: [phone]

Name: Monia MECHROUB

Email: [e-mail]

Tel: [phone]

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus and the Third Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus and the Third Supplement you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein. By accessing this document, you will be deemed to certify that you are located outside the United States and are not accessing the Base Prospectus from a location inside the United States.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PSPBUGDSISDDGXU

(END) Dow Jones Newswires

April 25, 2023 11:50 ET (15:50 GMT)